search
Back to results

Supercapsular Percutaneously Assisted Total Hip Approach for the Elderly With Femoral Neck Fractures

Primary Purpose

Femoral Neck Fractures

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Experimental group
Control group
Sponsored by
Shanghai Pudong Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Femoral Neck Fractures

Eligibility Criteria

75 Years - undefined (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Femoral head fractures as diagnosed by X-ran and CT;
  • Garden III, IV;
  • An age of > 75 years;
  • Both genders.

Exclusion Criteria:

  • Fractures with spinal cord injury;
  • Fractures with nerve injury;
  • Refusal to sign the informed consent.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Experimental

    Arm Label

    Experimental group

    Control group

    Arm Description

    Patients with femoral neck fractures are randomly assigned to undergo femoral head replacement via the SuperPATH approach in the experimental group.

    Patients with femoral neck fractures are randomly assigned to undergo femoral head replacement via the conventional posterior approach in the control group.

    Outcomes

    Primary Outcome Measures

    Harris hip scores
    To assess hip function recovery in patients. The hip function is assessed by Harris scores ranging from 0-100: excellent ≥ 90, good 80-90, fair 70-79, bad < 70. The higher scores indicate better hip function.

    Secondary Outcome Measures

    Length of surgical incision
    A smaller surgical incision causes smaller surgical trauma to patients.
    Intraoperative blood loss
    Less blood loss indicates the surgical practice is more normative and safe.

    Full Information

    First Posted
    April 26, 2017
    Last Updated
    April 26, 2017
    Sponsor
    Shanghai Pudong Hospital
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03134664
    Brief Title
    Supercapsular Percutaneously Assisted Total Hip Approach for the Elderly With Femoral Neck Fractures
    Official Title
    Supercapsular Percutaneously Assisted Total Hip Approach for the Elderly With Femoral Neck Fractures: a Prospective, Open-label, Randomized, Controlled Clinical Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    April 2017
    Overall Recruitment Status
    Unknown status
    Study Start Date
    January 2015 (Actual)
    Primary Completion Date
    June 2017 (Anticipated)
    Study Completion Date
    December 2017 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Shanghai Pudong Hospital

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    To test that the SuperPATH approach is more safe and reliable for hip functional recovery compared with the postolateral approach in the artificial hip replacement for femoral neck fractures in the elderly.
    Detailed Description
    Femoral neck fracture is one of the most common diseases in the elderly. Artificial hip replacement is currently the preferred treatment for femoral neck fractures, and characterized by no presence of postoperative bone nonunion, femoral head necrosis and other complications, though longer operative time and larger surgical incision are unavoidable. Patients undergoing artificial hip replacement can recover weight-bearing walk early after surgery, making rehabilitation rapid, to avoid a variety of complications, such as bed rests. Hip replacement via posterolateral approach is generally used, but limited by large incision, cutting off the extortor, and postoperative hip dislocation. The minimally invasive approach for hip replacement has the advantages of less blood loss and less trauma compared with conventional approaches. The supercapsular percutaneously-assisted total hip (SuperPATH) approach (Appendix 1) is consistent with the posterolateral approach in the anatomical landmark, preserving all the advantages of the posterior approach. Compared with the conventional approaches, the SuperPATH approach has no neurovascular interface that is uneasy to damage blood vessels and nerves during operation, reducing intraoperative blood loss, and retains all of the joint capsules and supinator muscles, significantly reducing the probability of postoperative dislocation of the hip. Osteotomy via this approach can be completed without hip dislocation, thus reducing incidence of vascular distortion and postoperative deep vein thrombosis. Hip replacement via the SuperPATH approach can be completed under direct vision rather than perspective inspection, and the surgical incision on the femur is made according to the femoral anteversion angle. In addition, this approach is also used for femoral intramedullary nail implantation. These surgical procedures are more likely to be grasped by clinicians. Preservation of the joint capsule and supinator muscles makes physical activities unrestricted and speeds up rehabilitation. Moreover, there is a corresponding reduction in the hospital stay and costs. However, SuperPATH technology is rarely reported in China as it has been introduced for a short time and in few hospitals. Previous studies have reported that SuperPATH approach for artificial hip replacement exhibits better short-term effect on elderly femoral neck fractures. In this trial, the follow-up period will be prolonged to 6 months in order to observe the short-to-mid term effect in the elderly with femoral neck fractures. Adverse events Postoperative adverse events including incision pain and infection, back muscle pain, spinal cord/nerve injury, length inequality of the lower limbs, prosthesis falling-off and prosthetic loosening will be recorded during the follow-up period. If severe adverse events occur, details including the data of occurrence, type of adverse events and therapeutic measures will be reported to the project manager and the institutional review board within 24 hours. Data collection, management, analysis, and open access Data collection Clinical data, including demographic data, disease diagnosis, accompanying diseases, and allergic history (drug allergy), will be collected and summarized using standardized case report forms. These data will be processed and recorded electronically. Data management Researchers will be responsible for data processing, confirming and locking. The locked data will be unable to be altered and preserved by the Pudong Hospital of Fudan University. In addition to these researchers, only the persons who have permission will have the right to query the database. Data analysis All data will be statistically analyzed by professional statisticians who will responsible for completing an outcome analysis report that will be submitted to the principle investigator who will be responsible for completing a research report. An independent data monitoring committee is responsible for data monitoring and management throughout the entire trial to ensure scientific accuracy, stringency, authenticity, and integrity.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Femoral Neck Fractures

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    Forty patients with femoral neck fractures admitted at Pudong Hospital of Fudan University, China are randomly divided into two groups.
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    40 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Experimental group
    Arm Type
    Experimental
    Arm Description
    Patients with femoral neck fractures are randomly assigned to undergo femoral head replacement via the SuperPATH approach in the experimental group.
    Arm Title
    Control group
    Arm Type
    Experimental
    Arm Description
    Patients with femoral neck fractures are randomly assigned to undergo femoral head replacement via the conventional posterior approach in the control group.
    Intervention Type
    Procedure
    Intervention Name(s)
    Experimental group
    Intervention Description
    Patients with femoral neck fractures are randomly assigned to undergo femoral head replacement via the SuperPATH approach in the experimental group.
    Intervention Type
    Procedure
    Intervention Name(s)
    Control group
    Intervention Description
    Patients with femoral neck fractures are randomly assigned to undergo femoral head replacement via the conventional posterior approach in the control group.
    Primary Outcome Measure Information:
    Title
    Harris hip scores
    Description
    To assess hip function recovery in patients. The hip function is assessed by Harris scores ranging from 0-100: excellent ≥ 90, good 80-90, fair 70-79, bad < 70. The higher scores indicate better hip function.
    Time Frame
    changes of baseline, week 1 and month 6 postoperatively
    Secondary Outcome Measure Information:
    Title
    Length of surgical incision
    Description
    A smaller surgical incision causes smaller surgical trauma to patients.
    Time Frame
    during the surgery
    Title
    Intraoperative blood loss
    Description
    Less blood loss indicates the surgical practice is more normative and safe.
    Time Frame
    during the surgery

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    75 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Femoral head fractures as diagnosed by X-ran and CT; Garden III, IV; An age of > 75 years; Both genders. Exclusion Criteria: Fractures with spinal cord injury; Fractures with nerve injury; Refusal to sign the informed consent.
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Lianghao Wu, Ph.D
    Organizational Affiliation
    Pudong Hospital of Fudan University
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    Undecided

    Learn more about this trial

    Supercapsular Percutaneously Assisted Total Hip Approach for the Elderly With Femoral Neck Fractures

    We'll reach out to this number within 24 hrs